Skip to main content
  • Saved

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

Source :

AbstractBACKGROUNDEpisodic cluster headache is a disabling neurologic disorder that is characterized by daily headache attacks that occur over periods of weeks or months. Galcanezumab, a humanized monoclonal antibody to calcitonin gene–related peptide, may be a preventive treatment for cluster headache.

Sign In or Register Today to Access This Content